Temporal and sequential changes of glial cells and cytokine expression during neuronal degeneration after transient global ischemia in rats by Yasuda, Y et al.
RESEARCH Open Access
Temporal and sequential changes of glial cells and
cytokine expression during neuronal degeneration
after transient global ischemia in rats
Y Yasuda
1*, T Shimoda
1,2, K Uno
1, N Tateishi
1,2, S Furuya
3, Y Tsuchihashi
4, Y Kawai
5, S Naruse
6 and S Fujita
1
Abstract
Background: How glial cells and cytokines are associated with the progression of delayed neuronal death induced
by transient global ischemia is still unclear. To further clarify this point, we studied morphological changes in glial
cells (microglial cells and astrocytes), and cytokine protein levels, during the progression of neuronal cell loss in
CA1 (Cornu Ammonis 1) of the hippocampus after transient global ischemia.
Methods: Morphological changes in glial cells were studied immuno-histochemically. Nine cytokines (IL-1a, IL-1b,
IL-2, IL-4, IL-6, IL-10, GM-CSF, IFN-g and TNF-a) were simultaneously measured by a multiplexed bead-based
immunoassay from 6 h to day21 after transient four vessel occlusion (4VO) in rats.
Results: During the process of neuronal loss, we observed four distinct phases: (1) lag phase day0-2 (no NeuN+
cell loss observed), (2) exponential phase day2-7 (NeuN+ cells reduced in number exponentially), (3) deceleration
phase day7-14 (reduction rate of NeuN+ cells became low), (4) stationary phase day14 onward (NeuN+ cell loss
progressed no longer). In the lag phase, activated glial cells were observed in the entire hippocampus but later
were gradually restricted to CA1. Cytokine protein levels in the lag and exponential phases were lower than in the
deceleration and stationary phases. IL-1a, IL-1b, IL-4, IL-6 and IFN-g in 4VO were significantly higher in all four
phases than in sham. Compared with sham level, GM-CSF was significantly high in the deceleration phase. TNF-a
was significantly high in both the deceleration and stationary phases.
Conclusion: Ischemic stress in 4VO activated glial cells in areas beyond CA1 in the lag phase. Pyramidal neurons
were injured in CA1 from the end of the lag phase and then neuronal cells reduced in CA1 in the exponential
phase. After neuronal death began, the influence of dead cells on glial cells and cytokine expression gradually
became stronger than the influence by ischemic stress. Therefore, from the deceleration phase, changes in glial
cells and cytokine production were likely caused by dead cells. Cytokine interaction in the microenvironment may
determine the functions of IL-1a, IL-1b, IL-4, IL-6 and IFN-g in all four phases. The function of GM-CSF and TNF-a
in the deceleration phase may be neurotrophic.
Background
Transient brain ischemia is known to cause delayed
neuronal death, resulting in an expansion of the injured
area after recirculation. Transient global ischemia model
is generally used to analyze the mechanism of neuronal
cell death caused by transient brain ischemia, because
transient global ischemia induces delayed pyramidal
neuronal cell death only in CA1 of the hippocampus on
day2 or 3 after recirculation [1-3]. Transient global
ischemia activates microglial cells and astrocytes, and
up-regulates the production of inflammatory cytokine.
Activated microglial cells and astrocytes play an impor-
tant role in the progression of ischemic injury by produ-
cing cytokines [4]. Suppressing microglial cell activation
protects against neuronal death induced by transient
global ischemia [5].
An increase in inflammatory cytokines, such as IL-1b,
IL-6 and TNF-a at early time points after transient glo-
bal ischemia has been reported [6-11]. Antibodies that
neutralize IL-1b or TNF-a, the soluble form of IL-1b or
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reduce the injury caused by brain ischemia in rodents
[12-16]. These reports suggest that IL-1b and TNF-a
trigger neuronal death in CA1 and that inflammatory
cytokines are closely associated with neuronal degenera-
tion in ischemic injury [9,17-20]. Brain born- as well as
peripheral-born cytokines contribute to ischemic injury
progression and repair [21,22].
Inflammatory cytokines are individually pleiotrophic,
and vary in pleiotrophic aspects in combination with
other cytokines. Since cytokine interaction affects cyto-
kine function, it is necessary to study multiple cytokines
simultaneously in order to understand their role in the
progression of ischemic injury. Cytokine production is
generally measured through mRNA levels [23]. How-
ever, since newly synthesized cytokine mRNA is not
always transcribed to produce protein, it is more suita-
b l et os i m u l t a n e o u s l ym e a s u r et h ec h a n g e si np r o t e i n
levels of multiple cytokines for an accurate understand-
ing of cytokine function [24,25].
Knowledge of the pattern of multiple cytokine expres-
sion in the hippocampus is required to understand the
inflammation associated with neuronal death induced by
transient global ischemia. However to date, there are no
known reports about the profile of multiple cytokine
protein levels in the hippocampus.
The aim of this study is to reveal how glial cells and
cytokines are related to neuronal cell degeneration
induced by transient global ischemia in rats. A global
ischemic model was prepared by a 10 min four-vessel
occlusion (4VO) followed by re-circulation in rats. After
recirculation, the changes in glial cells and cytokine
expression during neuronal reduction in CA1 were stu-
died by immuno-histochemical methods and multi-
plexed bead-based immunoassay, respectively. A total of
nine cytokines, IL-1a (interleukin-1a), IL-1b, IL-2, IL-4,
IL-6, IL-10, GM-CSF (granulocyte-macrophage colony
stimulating factor), IFN-g (interferon-g)a n dT N F - a
(tumor necrosis factor-a), were simultaneously mea-
sured in this study.
Materials and methods
Animals and surgical procedures
Male Wistar rats (Cr1j:WI, 7 weeks old) obtained from
Charles River Japan Inc. (Hamamatsu, Japan) were
housed in a temperature controlled room for seven days
prior to surgery. All experiments were conducted in
accordance with the Guidelines for Animal Experiment
compiled by the Animal Care and Animal Use Ethical
Committee at the Louis Pasteur Center for Medical
Research.
Rats were subjected to transient global ischemia by
clamping the carotid arteries bilaterally utilizing a com-
bination of methods described in previous reports
[1,2,26]. In brief, 24 hours before inducing ischemia, the
rats were anesthetized with pentobarbital sodium and
the bilateral vertebral arteries were heat-cauterized at
each alar foramen using a soldering iron. Both common
carotid arteries were then gently isolated and a silicone
tube placed around each vessel. The following day, both
common carotid arteries were occluded with vascular
clamps for 10 min. In sham groups, the same operation
was performed but without occlusion of both carotid
arteries. Only rats that had lost their righting reflexes
during the period of ischemia were used for this study.
The changes in glial cells and cytokines were studied on
day0.25 (6 hr), 1, 2, 3, 5, 7, 10, 14 and 21 post re-circu-
lation. In this rat model, only CA1 pyramidal neurons
died (Figure 1).
Immunohistochemistry
The rats were anesthetized with diethyl ether and per-
fused with saline and then perfusion-fixed with 4% par-
aformaldehyde in 0.1 M phosphate-buffer (PB), pH 7.4.
After perfusion-fixation, the brain was dissected and
post-fixed for one day in the same fixative. Subse-
quently, the tissue blocks were embedded in O.C.T.
medium (Sakura Finetech Japan Co., Ltd, Tokyo, Japan)
and were frozen at -80°C. Coronal 14 μmt h i c ks e c t i o n s
were sequentially cut in a cryostat.
The sections were immersed in Block-One (Nacalai
Tesque Inc., Kyoto, Japan) for 30 min in order to block
non-specific binding, and were incubated with the pri-
mary antibodies at 4°C overnight. As primary antibodies,
anti-neuronal nuclei (NeuN) antibody (I:200, Millipore
Ltd., Billerica, MA, USA), anti-ionized calcium binding
Figure 1 Neuronal cell death only in CA1 of hippocampus.A
shows the structure of the hippocampus. CA1-3: Cornu Ammonis 1-
3, Or: oriens layer of CA1, Py: pyramidal cell layer of CA1, Rad:
radiatum layer of CA1, Lmol: lacunosum-molecular layer of CA1, GD:
dentate gyrus.B shows microscopic images of the hippocampus
immunostained with an anti-NeuN antibody. On day14, NeuN+ cell
reduction was observed in CA1 but not in CA2-3.
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Page 2 of 10adaptor molecule 1 (Iba1) antibody (1:200, Wako Pure
Chemical Industries Ltd., Osaka, Japan), and anti-glial
fibrillary acidic protein (GFAP) antibody (Progen Bio-
technik Gmbh, Heiderberg, GM) were prepared to
detect neuronal nuclei, microglial cells/macrophages,
and astrocytes, respectively. ABC Elite kit (Vector
Laboratories Inc., Burlingame, CA, USA) as signal
enhancer, and chromogen solution including di-amino-
benzidine (DAB, Wako Pure Chemical Industries, Ltd.)
and ammonium nickel(II) sulfate hexahydrate (Nacalai
Tesque Inc.) [27] were used for the conventional micro-
scopic observation.
The primary area for histological observation in the
hippocampus was CA1 which consists of oriens layer
(Or), pyramidal cell layer (Py), radiatum layer (Rad) and
lacunosum-molecular layer (Lmol) (Figure 1).
Protein preparation for cytokine measurements
Rats were decapitated under diethyl ether anesthesia and
the brains were rapidly removed and dissected into 2
mm thick coronal slices. A section of the hippocampus
was removed from the coronal slice and rapidly frozen
in dry ice and kept at -80°C.
In preparation for extracting the protein from the hip-
pocampus slices, 100 μl cell lysis buffer (Bio-Plex Cell
Lysis Kit, Bio-Rad Laboratories Inc., Hercules, CA, USA)
containing protease inhibitor (Sigma P8340, Sigma
Ardlich Co., St. Louis, MO, USA) was added to the sam-
ples. The samples were sonicated on ice using Handy
Sonic UR-20P (Tomy Seiki Co. Ltd., Tokyo, Japan) and
centrifuged at 14,000 × g for 5 min at 4°C, the superna-
tant were then transferred to a tube. Using the Bradford
method (Protein Assay Kit, Bio-Rad Laboratories Inc.),
we determined the protein concentration of the super-
natant and adjusted it to 500 μg/ml using cell lysis buf-
fer for immunoassay.
Cytokines were measured using a multiplexed bead-
based immunoassay kit, Bio-Plex rat 9 plex A panel
(Bio-Rad Laboratories Inc.), in conjunction with a Cyto-
kine Reagent kit (Bio-Rad Laboratories Inc.) and a Bio-
Plex Protein Array System (Bio-Rad Laboratories Inc.).
The 9 Plex A panel consisted of the following analytes:
IL-1a,I L - 1 b,I L - 2 ,I L - 4 ,I L - 6 ,I L -10, GM-CSF, IFN-g
and TNF-a. Results were analyzed using Bio-Plex Man-
ager 30 software (Bio-Rad Laboratories Inc.). The relia-
bility and accuracy of the Bio-Plex rat cytokine assay kit
is supported by prior reports [28].
Statistical analysis
For statistical analysis, half the value of the lowest limit
was used as a substitute for values that fell out of range
(below the lowest limit). Data are presented as mean ±
SEM. Cytokine changes during the process of neuronal
cell degeneration in CA1 were analyzed by ANOVA
followed by the Dunnett method. Differences between
4VO and sham groups at each time point were analyzed
with an unpaired t test. P values of 0.05 or less were
considered statistically significant.
Results
Reduction of CA1 pyramidal neurons
In this global model, neuronal damage was visible only
in CA1 of the hippocampus and no other region. The
reduction in the number of CA1 pyramidal neurons
after global ischemia was studied by immunostaining
with anti-NeuN antibody and then NeuN+ cells were
counted (Figure 2). The number of NeuN+ cells in CA1
o nd a y 2w a ss l i g h t l yd i f f e r e n tf r o mt h a ti nn o r m a lr a t s .
Even though NeuN+ cells reduced on day3, the number
of surviving cells was not statistically different from nor-
mal rats, but a statistically significant reduction was
observed on day5. In the sham group, no neuronal
reduction was observed.
These results reveal that the process of neuronal
reduction can be divided into four phases: (1) lag phase
when very little NeuN+ cell loss was observed (day0-2),
(2) exponential phase when NeuN+ cells reduced expo-
nentially (day2-7), (3) deceleration phase when the rate
Figure 2 Reduction of NeuN+ cells after recirculation.Aa r e
microscopic images of a part of CA1 Py, indicated by the rectangle
in Figure 1A, immunostained with an anti-NeuN antibody. On day3,
NeuN+ cell reduction was observed. This reduction continued from
day5 to day14. Graph B shows the reduction curve of NeuN+ cells
in CA1 Py. In this graph, NeuN+ cell percentage is calculated by
dividing the no. of NeuN+ cell in 4VO by the no. of NeuN+ cell in
the normal rats in an area of the same size. Each data point shows
the mean ± SEM of results from 5 rats. The amount of NeuN+ cells
in CA1 on day3, 5, 7, 14 and 21 were 90 ± 5.1, 55 ± 2.1, 34 ± 3.5, 12
± 2.3% and 17 ± 5%, respectively. The process of neuronal
reduction after recirculation was divided into 4 phases: lag,
exponential, deceleration and stationary phases.
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Page 3 of 10of reduction became lower (day7-14), (4) stationary
phase when additional neuronal loss was no longer
observed (after day14).
Activation of microglial cells
After recirculation, microglial cell activation was
immuno-histochemically studied using anti-Iba1 anti-
body (Figure 3). Day2 post-recirculation, Iba1+ cells in
the entire hippocampus were slightly hypertrophic com-
pared with sham samples. On day3, Iba1+ large amoe-
boid cells were observed in CA1 and dentate gyrus
(Figure 3). Iba1+ clusters consisting of 2 or 3 cells were
observed around Py on day3. Apart from on day3, Iba1+
clusters were not observed at other time points. On
day5 post-recirculation, Iba1+ cells increased especially
in Rad, additionally Iba1+ small amoeboid cells with
weak immunostaining intensity in Py were also
observed. On day7, the shape of Iba1+ hypertrophic
cells varied among layers: Iba1+ thin-rod cells with
short processes were observed in Rad, small amoeboid
cells in Py and hypertrophic cells with many processes
in Or and Lmol. These morphological characteristics in
CA1 not only remained but were accentuated on day21.
Our finding agrees with Sugawara et al. [29] who
reported the appearance of rod cells after transient glo-
bal ischemia. In sham-operated rats, the morphological
change of Iba1+ cells was slight, but clearly recognizable
from the immunostaining intensity and morphological
change of their processes.
These results mean that microglial cell morphology is
affected even by sham operation that stops blood flow
in the bilateral vertebral arteries only. These finding also
suggests that in the lag phase, microglial cells are acti-
vated in the entire hippocampus. After neuronal cell
reduction began, the distribution of activated microglial
cells was gradually restricted to CA1 of the
hippocampus.
Activation of astrocytes
The activation of astrocytes was studied by immunos-
taining for GFAP (Figure 4). In 4VO on day2, GFAP+
cells in the entire hippocampus were more hypertrophic
than in the sham samples. Astrocytes were also more
hypertrophic in CA1 than in CA2 from day3 to 21. The
immunostaining intensity increased on day7 and 21. In
sham, no remarkable morphological changes were
observed except slight changes in CA1. These results
show that activated astrocytes were distributed in the
entire hippocampus in the lag phase, but were gradually
restricted to CA1 in later phases.
Changes in cytokine protein levels in the hippocampus
IL-1a,I L - 1 b,I L - 2 ,I L - 4 ,I L - 6 ,I L -10, GM-CSF, IFN-g
and TNF-a in the hippocampus post-recirculation were
simultaneously measured in 4VO and sham from 6 h
(day 0.25) until day21, and the changes were analyzed
by ANOVA (Figure 5).
Cytokine expression was affected by both 4VO and
sham operation (Figure 5). IL-1a,I L - 1 b,I L - 2 ,I L - 4 ,I L - 6 ,
GM-CSF, IFN-g and TNF-a protein levels were signifi-
cantly higher on day7, compared with their levels on
day5. In 4VO, IL-1a,I L - 1 b,G M - C S F ,I F N - g and TNF-a
high protein levels remained until day21. IL-2 protein
level decreased from 6 h to day5, increased from day7
until day10 and decreased again from day14. IL-6 protein
level peaked on day2, decreased until day5, increased
again on day7 and remained steady until day21. In sham,
even though the protein levels of IL-1a, IL-1b, IL-2, IL-4,
IL-6, IFN-g and TNF-a increased on day7, they decreased
on day10, and afterward, these protein levels did not
change significantly. No significant difference in IL-10
protein level was observed between day5 and 7.
The difference in protein level between 4VO and
sham at each time point was analyzed using student t-
test (Table 1). At 6 h IL-1a,I L - 1 b,I L - 2 ,I L - 4 ,I L - 6 ,
GM-CSF, IFN-g and TNF-a protein levels did not differ
significantly between 4VO and sham. On day1 however,
IL-1a and IL-6 levels were significantly higher (p <
0.05) in 4VO than in sham. On day2, IL-1b and IL-4
levels, in addition to IL-1a, and IL-6, were significantly
higher than in sham (p < 0.05). Afterward IL-1a,I L - 1 b,
IL-4, IL-6 and IFN-g levels were high (0.05 < p < 0.1) or
significantly high (p < 0.05) until day5. On day7, only
IL-1b level was significantly higher (p < 0.05) and IL-2
level significantly lower (p < 0.05) than sham. From
day10 to 14, IL-1a,I L - 1 b,I L - 4 ,I L - 6 ,G M - C S F ,I F N - g
and TNF-a levels were high (0.05 < p < 0.1) or signifi-
cantly high (p < 0.05), compared with their sham levels.
On day21, IL-1a,I L - 1 b,I L - 4 ,I L - 6 ,I F N - g and TNF-a
levels in 4VO were significantly higher than in sham
and GM-CSF decreased to the sham level. IL-2 protein
level at each time point in 4VO was similar to, or lower
than the sham level. IL-10 protein level at each time
point was not significantly different between 4VO and
sham.
Discussion
In this experiment, the process of neuronal death caused
by transient global ischemia was analyzed, focusing on
the prolonged changes in glial cells and multiple cyto-
kine expression (IL-1a,I L - 1 b, IL-2, IL-4, IL-6, IL-10,
GM-CSF, IFN-g and TNF-a). The reduction curve of
neuronal cells in CA1 after 4VO (Figure 3) was S
shaped. The process of neuronal cell degeneration was
divided into four phases: lag, exponential, deceleration
and stationary phases. We found that the changes of
glial cell morphology and cytokine expression differed
among these four phases of neuronal reduction.
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Page 4 of 10Figure 3 Change of microglial cells after recirculation. Anti-Iba1 antibody was used to immunostain microglial cells. Rows A, B, C, and D
represent different sections of the hippocampus. A: the entire hippocampus in 4VO, B: border between CA1 and CA2 in 4VO, C: larger
magnification of CA1 of the hippocampus in 4VO, D: larger magnification of CA1 of the hippocampus in sham. C and D were taken from the
rectangular area shown in Figure 1A. Arrows and arrow heads in row A show Py and dentate gyrus, respectively. In row B, the upper and lower
sides of the images show CA1 and CA2, respectively. Arrows and arrowheads in row C indicate amoeboid microglial cells and rod cells,
respectively. On day2, microglial cells began to be hypertrophic in the entire hippocampus. On day3, amoeboid cells (arrow) were observed in
CA1 and clusters including 2 or 3 microglial cells (large arrows) were around Py. Between day5 and 21, Iba1+ amoeboid cells (arrow) in Py, rod
cells with short processes in Rad (arrow head) and hypertrophic cells in Or and Lmol of CA1 in the hippocampus were observed.
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Page 5 of 10Glial cell activation after 4VO
In this 4VO experiment, activated microglial cells and
astrocytes were observed in the entire hippocampus in
the lag phase. After neuronal reduction was observed,
both microglial cells and astrocytes gradually became
more hypertrophic in CA1 than CA2-3. These results
suggest that transient global ischemia activates micro-
glial cells and astrocytes ina na r e aw i d e rt h a nC A 1o f
the hippocampus in the lag phase but after the exponen-
tial phase, the activation of both glial cells was gradually
restricted mainly to CA1. Glial cells in CA1 also
increased in the deceleration phase.
Figure 4 Morphological change of astrocytes after recirculation. Astrocytes were detected by immunostaining for GFAP. Each image
represents one time point. Rows A, B, C, and D represent a different section of the hippocampus. A: the entire hippocampus in 4VO, B: border
between CA1 and CA2 in 4VO, C: a part of CA1 of the hippocampus in 4VO, D: a part of CA1 of the hippocampus in sham. C and D were taken
from the rectangular area shown in Figure 1A. In row B, the upper and lower sides of the images show CA1 and CA2, respectively. On day2,
astrocytes were more hypertrophic (C) than in sham (D). From day3 to day21, astrocytes in CA1 were more hypertrophic than those in CA2 of
the hippocampus.
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Page 6 of 10Iba1+ clusters around Py on day3 consisted of acti-
vated microglial cells in the prophase or metaphase of
the mitosis (see additional file 1). Fujita et al. [30]
prior reported that microglial cells actively prolifer-
ated in the initial stage of brain injury supports our
findings. The existence of Iba1+ clusters on day3
indicates that the activated microglial cells, which
may have migrated around Py or had already existed
there, actively proliferated and Iba1+ clusters were
created.
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Figure 5 The change of cytokine protein level in hippocampus after recirculation. All protein levels were simultaneously measured using a
multiplexed bead-based immunoassay. Each data point indicates the mean ± S.E.M. (sham = 6, 4VO = 6-8). *p < 0.05, significantly different from sham.
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Page 7 of 10In order to shed more light on the relationship
between neuronal death and NeuN+ cell loss, we stu-
died DNA fragmentation using terminal deoxynucleoti-
dyl transferase dUTP nick end labeling (TUNEL)
staining. The result from this staining showed that neu-
ronal DNA damage had already started on day2 (see
additional file 2). There was a time lag between when
neuronal death was detected by TUNEL and the occur-
rence of NeuN+ cell loss.
Our results, combined with those from previous
reports [29], suggest that glial cell activation is mainly a
result of transient global ischemia in the lag phase. Neu-
ronal cell death gradually evoked glial cell activation in
the exponential phase and then dead cells stimulated
the proliferation of glial cells.
Cytokine expression after 4VO
In previous experiments using the rat model, an increase
in IL-1b and IL-6 mRNA levels after recirculation within
hours after transient global ischemia was reported
[6,8,31,32]. In our experiment, we did not observe an
increase in inflammatory cytokine protein levels at 6 h,
but our immuno-histochemical study showed that in the
hippocampus, IL-1b immuno-intensity in astrocytes was
higher in 4VO than in sham (see additional file 3).
These results point to the possibility that IL-1b is
related to neuronal damage induced by 4VO. On day1,
an increase in IL-1a and IL-6 was detected by bead-
based immunoassay. The beads assay and immuno-
histochemical study delivered different results, maybe
due to the fact that cytokine in the soluble form was
reduced during brain fixation and immunostaining pro-
cess. A previous report using gerbil model showed that
TNF-a protein level increased at 1 h, decreased to the
control level and increased again on day1 [7]. It was
further reported that IL-1b and IL-6 protein levels
increased after 6 h and 3 h respectively, decreased and
then increased again on day1. The disparity between
Saito et al’s results [7] and those of this study may be
due to the difference in the animal model or breeder
that was used as well as the fact that we used a bead-
based assay while Saito et al. employed an enzyme
immunoassay. An increase of IL-1b and TNF-a in the
early phase after re-circulation is thought to trigger a
signal transduction towards neuronal cell death in CA1.
In our rat model, IL-1b,I L - 6a n dT N F - a protein levels
may have increased earlier than 6 h after re-circulation
and then decreased to the sham level at 6 h.
The protein levels of IL-1a,I L - 1 b,I L - 2 ,I L - 4 ,I L - 6 ,
GM-CSF, IFN-g and TNF-a were up-regulated on day7
in both 4VO and sham, but protein levels in other cyto-
kines except IL-1b and IL-2 were not significantly differ-
ent between 4VO and sham. On the same day, all glial
cells in CA1 were strongly activated in 4VO but in
sham there was only a slight morphological change of
glial cells. We observed also that more microglial cells
in 4VO on day7 was more activated than on day5. Addi-
tionally, our immuno-histochemical study of IL-1b dis-
tribution in the hippocampus showed that IL-1b
staining intensity in activated astrocytes in 4VO was
stronger than sham on day7 (see additional file 3). In
4VO, activated astrocytes and microglial cells in the hip-
pocampus might be involved in the increase in cytokine
levels on day 7. In sham, these results suggest that sham
operation (heat-cauterization of alar foramen) may affect
cytokine protein levels in the hippocampus without any
pronounced activation of microglial cells and astrocytes.
These results may also indicate that in addition to cyto-
kines produced in glial cells, peripheral-born cytokines
and/or brain-born cytokines produced outside of the
hippocampus can contribute to the increase in cytokine
protein levels on day7 and cytokine producing cells might
be different between 4VO and sham. On day7, only IL-1b
was significantly higher in 4VO than in sham and IL-2 in
sham was significantly higher than in 4VO. The change in
cytokine protein levels after day10 was different in 4VO
and sham. In 4VO, IL-1a,I L - 1 b,I L - 4 ,I L - 6 ,G M - C S F ,
IFN-g and TNF-a protein levels were higher or signifi-
cantly higher than in sham and these cytokines maintained
a high protein level during the deceleration phase. In
sham, on the other hand, most cytokines were up-regu-
lated on day7 and then decreased on day10. It is possible
that day7 may be an important point in 4VO and sham
when the continuation or end of inflammation is decided.
IL-2 is a neuro-regulatory cytokine in the brain [33] and
IL-1b has both neurotrophic and neurotoxic functions.
Table 1 Cytokines expressed significantly higher or lower than sham in each phase of neuronal reduction. P < 0.05 by
t-test
~lag phase exponential phase deceleration phase stationary phase~
day after recirculation day1 day2 day3 day5 day7 day10 day14 day21
IL1a, IL-6 IL-1a, IL-1b IL-1a, IL-1b IL-1a, IL-4 IL-1b IL-1a, IL-1b IL-1a, IL-4 IL-1a, IL-1b
higher IL-4, IL-6 IL-6, IFN-g IFN-g IL-4, IL-6 IL-6,GM-CSF IL-4, IL-6
GM-CSF, IFN-g, TNF-a IFN-g,TNF-a
TNF-a
lower none none none none IL-2 none none IL-2
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in regulating other cytokine expression after day7.
In the exponential and deceleration phases the protein
levels of IL-1a,I L - 1 b, IL-4, IL-6 and IFN-g were signifi-
cantly higher in 4VO than in sham, thereby making it
difficult to ascertain how these cytokines contribute to
the process of neuronal loss. IL-1a,I L - 1 b,I L - 6a n d
TNF-a have both neurotoxic and neurotrophic func-
tions. The role of each cytokine in the progression of
neuronal cell death or repair might be revealed through
cytokine interaction. It could be that the interaction
among cytokines with protein levels that were signifi-
cantly higher than sham in the lag and exponential
phases might lead to the progression of neuronal cell
death. In the deceleration and early stationary phases
after day7, glial cells in CA1 of the hippocampus
remained activated in 4VO but were not activated in
sham. In the deceleration and early stationary phases
after day7, the interaction among cytokines with protein
levels that were significantly higher in 4VO than in
sham, may have led to the end of neuronal death, and
the cleaning of dead cell debris mainly with the help of
activated microglial cells/macrophages. However, more
studies are required to fully understand this relationship.
In addition to understanding the profile of multiple
cytokines after re-circulation, we believe that knowing
when neuronal death is triggered may also be important
for developing a wider therapeutic window.
Significantly higher protein level in GM-CSF was
observed only in the deceleration phase in 4VO, com-
pared with sham. GM-CSF counteracts apoptosis, is
neurotrophic and stimulates the differentiation of granu-
locyte/macrophage [34]. GM-CSF administration sup-
presses delayed neuronal cell death after focal ischemia
[35]. An increase in GM-CSF only in the deceleration
phase suggests that GM-CSF may help to protect neuro-
nal cells from apoptosis and repair the injury induced by
transient global ischemia.
No significant difference between 4VO and sham in
IL-10, an anti-inflammatory cytokine, was observed after
transient global ischemia in our experiment but it is
reported that IL-10 administration suppresses neuronal
cell reduction caused by ischemia [36].
Suppressing the function of IL-1a,I L - 1 b and TNF-a
[12-16], anti-inflammatory cytokines such as IL-10, and
delayed neuronal cell death suppressors such as GM-
CSF, are effective for suppressing delayed neuronal cell
death after transient global ischemia. Detailed informa-
tion of the function of each cytokine in the lag, expo-
nential and deceleration phases might be helpful in
developing methods for mitigating ischemic insult.
More information about the relationship between neu-
ronal death and cytokine profile can lead to the develop-
ment of new cytokine therapy based on the changes in
cytokine profile and the progression time of neuronal
death after transient global ischemia.
Conclusions
The changes in glial cells and cytokine expression were
characteristic in each phase of neuronal cell degenera-
tion. In the lag phase, glial cells and cytokine expression
were mainly affected by ischemic stress, and from the
exponential phase dead cells gradually influenced the
change in glial cells and cytokine expression. The func-
tion of IL-1a,I L - 1 b,I L - 4 ,I L - 6a n dI F N - g may be
decided by cytokine balance in the microenvironment.
In the lag and exponential phases, cytokine balance may
shift to being more neurotoxic and in the deceleration
and stationary phase to being more neurotrophic.
Additional material
Additional file 1: Mitosis of microglial cells after recirculation.
Presence of activated microglial cells was detected by immunostaining
for Iba1 and DNA was stained with propidium iodide (PI) after treatment
with RNase. Red and green indicate DNA and Iba1, respectively.
Activated microglial cells in meta- (arrow) and pro - (arrow head) phases
were observed in CA1.
Additional file 2: TUNEL positive pyramidal neuron in CA1 after re-
circulation. Fragmented DNA was detected, using DeadEndTM
Colorimetric TUNEL System (Promega Co., Wisconsin, USA). Methyl green
was used to counter-stain. Arrows show TUNEL+ neuronal cells. TUNEL+
neuronal cells were observed on day2 after re-circulation.
Additional file 3: Immunostaining images for GFAP and IL1b at 6 h
and on day7 after re-circulation. Red and green indicate GFAP and IL-
1b, respectively. IL-1b was distributed in GFAP+ cells. Staining intensity in
4VO was stronger than in sham.
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CA: Cornu Ammonis in hippocampus; DAB: di-aminobenzidine; DG: dentate
gyrus; GFAP: glial fibrillary acidic protein; GM-CSF: granulocyte-macrophage
colony stimulating factor; Iba1: ionized calcium binding adaptor molecule 1;
IFN-γ: interferon-γ; IL: interleukin; Lmol: lacunosum-molecular layer in CA1;
NeuN: neuronal nuclei; Or: oriens in CA1; Py: pyramidal cell layer in CA1; Rad:
radiatum layer in CA1; TNF-α: tumor necrosis factor-α; TUNEL: terminal
deoxynucleotidyl transferase dUTP nick end labeling
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